y 27632 has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pernis, AB; Ricker, E; Rozo, C; Weng, CH; Yi, W | 1 |
| Akhmetshina, A; Dees, C; Distler, JH; Distler, O; Pileckyte, M; Schett, G; Spriewald, BM; Szucs, G; Zwerina, J | 1 |
1 review(s) available for y 27632 and Sclerosis, Systemic
| Article | Year |
|---|---|
Rho Kinases in Autoimmune Diseases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Cell Movement; Cell Proliferation; Cell Survival; Cytoskeleton; Gene Expression; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Myeloid Cells; Osteoarthritis; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Scleroderma, Systemic; T-Lymphocytes | 2016 |
1 other study(ies) available for y 27632 and Sclerosis, Systemic
| Article | Year |
|---|---|
Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
Topics: Adult; Aged; Amides; Case-Control Studies; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Extracellular Matrix; Female; Fibroblasts; Humans; Male; Matrix Metalloproteinases; Middle Aged; Platelet-Derived Growth Factor; Pyridines; rho-Associated Kinases; Scleroderma, Systemic; Skin; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta | 2008 |